infecti
bursal
diseas
viru
ibdv
etiolog
agent
infecti
bursal
diseas
ibd
highli
contagi
diseas
chicken
viru
replic
cytoplasm
infect
cell
target
precursor
antibodyproduc
b
cell
bursa
fabriciu
bf
infect
viru
lead
sever
immunosuppress
character
destruct
b
cell
present
bf
induc
immunodepress
increas
suscept
pathogen
two
distinct
serotyp
ii
recogn
ibdv
serotyp
viru
strain
differ
markedli
virul
classic
virul
ibdv
strain
caus
hemorrhag
inflamm
bf
wherea
variant
strain
caus
rapid
bursal
atrophi
without
evok
inflamm
respons
contrast
serotyp
serotyp
ii
virus
natur
avirul
chicken
ibd
one
import
diseas
affect
poultri
industri
worldwid
ibdv
member
birnavirida
famili
genom
consist
two
segment
doublestrand
rna
design
kb
b
kb
segment
two
partial
overlap
open
read
frame
orf
smaller
orf
encod
nonstructur
protein
kda
requir
viral
replic
larger
orf
encod
polyprotein
precursor
order
polyprotein
appear
cotransl
process
proteolyt
activ
viral
proteas
gener
precursor
process
c
terminu
becom
cleavag
three
bond
bond
structur
protein
form
viru
capsid
segment
b
encod
known
multifunct
protein
polymeras
cap
enzym
activ
success
infect
host
virus
exploit
cellular
resourc
time
avoid
defens
reaction
host
organ
one
common
obstacl
face
viru
overwhelm
stoichiometr
imbal
target
protein
encod
viru
overcom
mani
virus
evolv
abil
util
host
proteas
machineri
direct
cellular
protein
degrad
surviv
replic
proteasom
larg
multisubunit
complex
select
degrad
intracellular
protein
involv
wide
varieti
proteolyt
mediat
intracellular
process
cell
cycl
progress
apoptosi
metabol
regul
transcript
control
major
protein
target
proteasom
tag
polyubiquitin
serv
signal
degrad
process
protein
degrad
substrat
first
tag
ubiquitin
three
enzym
ubiquitinactiv
enzym
enzym
ubiquitinconjug
enzym
enzym
ubiquitin
ligas
ligas
polyubiquitin
protein
rapidli
degrad
proteasom
recent
studi
implic
pathway
might
play
key
role
viru
infect
facilit
activ
requir
variou
aspect
viru
life
cycl
entri
replic
enhanc
cell
surviv
viral
releas
addit
proteasom
inhibitor
reduc
replic
progeni
releas
sever
virus
includ
coxsackieviru
human
cytomegaloviru
human
immunodefici
viru
type
sendai
viru
ibdv
previous
shown
induc
apoptosi
vitro
vivo
recent
demonstr
ibdvinduc
apoptosi
activ
activ
complet
inhibit
treatment
proteasom
inhibitor
suggest
proteasom
inhibitor
block
ibdvinduc
apoptosi
whether
inhibit
ibdvinduc
apoptosi
treatment
proteasom
inhibitor
associ
reduct
viral
replic
still
unclear
howev
result
rais
possibl
pathway
may
use
ibdv
infect
promot
viral
replic
infect
thu
present
studi
attempt
explor
role
proteasom
inhibit
ibdv
infect
mechan
contribut
proteasom
inhibitor
suppress
ibdv
replic
cultur
cell
relationship
ibdvinduc
apoptosi
viral
replic
chicken
embryo
fibroblast
cef
cell
line
maintain
dulbecco
modifi
eagl
medium
dmem
gibco
supplement
fetal
bovin
serum
fb
uml
penicillin
g
streptomycin
humidifi
incub
ibdv
strain
lm
cef
cellsadapt
viru
use
studi
cell
infect
multipl
infect
moi
ibdv
strain
lm
min
cell
wash
pb
cultur
fresh
dmem
medium
contain
fetal
calf
serum
inhibitor
experi
cell
adsorpt
ibdv
incub
proteasom
inhibitor
lactacysin
calbiochem
san
diego
ca
h
cell
incub
dmem
medium
without
proteasom
inhibitor
amount
ibdv
produc
measur
monolay
cell
cell
supernat
serial
dilut
inocul
monolay
cell
follow
h
incub
fresh
dmem
medium
ad
incub
three
day
postinfect
pi
cytopath
effect
cpe
observ
microscopi
viru
titer
determin
per
ml
modifi
salt
mt
assay
measur
mitochondri
function
use
determin
cell
viabil
accord
manufactur
instruct
promega
twentyon
hour
pi
cell
incub
h
mt
solut
absorb
measur
nm
elisa
reader
convers
mt
aqueou
solubl
formazan
product
accomplish
dehydrogenas
enzym
found
metabol
activ
cell
quantiti
formazan
product
measur
directli
proport
number
live
cell
cultur
ibdvinfect
cell
also
examin
morpholog
chang
phasecontrast
microscopi
infect
cell
grown
plate
incub
ibdv
strain
lm
min
moi
ad
dmem
incub
follow
incub
cell
h
pi
wash
pb
fix
min
room
temperatur
rt
paraformaldehyd
pfa
pb
fixat
cell
block
pb
bsa
rt
h
primari
antibodi
guinea
pig
polyclon
antibodi
dilut
pb
bsa
incub
cell
h
wash
pb
cell
incub
goat
antiguinea
pig
fitcconjug
antibodi
dako
dilut
pb
bsa
h
cell
wash
three
time
pb
examin
use
fluoresc
microscopi
total
cell
rna
prepar
virusinfect
cell
h
treat
variou
concentr
use
trizol
rna
extract
reagent
invitrogen
revers
transcript
rt
pcr
realtim
rtpcr
assay
use
primer
pair
target
nt
region
normal
primer
sens
antisens
separ
reaction
rt
reaction
perform
avian
myeloblastosi
viru
revers
transcriptas
roch
use
antisens
primer
amplif
protocol
follow
instruct
lightcycl
fast
start
dna
masterplu
sybr
green
kit
roch
pcr
paramet
consist
initi
denatur
min
follow
cycl
subsequ
melt
curv
analysi
c
valu
determin
perform
use
roch
lightcycl
softwar
version
sampl
run
triplic
rel
amount
target
viral
mrna
normal
mrna
sampl
cell
grown
flask
h
pi
collect
centrifug
g
min
whole
cell
lysat
prepar
cell
pellet
wash
twice
icecold
pb
ph
lyse
vigor
vortex
guanidin
hydrochlorid
contain
mm
ph
mm
edta
mm
mm
phenylmethylsulfonyl
fluorid
pmsf
cytosol
extract
prepar
previous
describ
cell
pellet
wash
twice
icecold
pb
resuspend
buffer
mm
sucros
mm
hepe
mm
kcl
mm
mm
edta
mm
egta
mm
dithiothreitol
mm
pmsf
ph
cell
homogen
centrifug
twice
g
min
supernat
centrifug
g
h
result
supernat
cytosol
extract
frozen
aliquot
subsequ
experi
whole
lysat
cytosol
extract
subject
sdspolyacrylamid
gel
electrophoresi
sdspage
immunoblot
analysi
protein
whole
cell
lysat
resolv
sdspage
blot
onto
nitrocellulos
nc
membran
stratagen
semidri
transfer
cell
biorad
transblot
sd
membran
block
h
rt
block
buffer
tbst
mm
ph
mm
nacl
contain
skim
milk
powder
prevent
nonspecif
bind
incub
guinea
pig
antibodi
rt
h
cytochrom
c
detect
protein
sampl
cytosol
extract
resolv
sdspage
transfer
nc
membran
describ
rabbit
anticytochrom
c
antibodi
santa
cruz
biotechnolog
dilut
block
buffer
membran
wash
three
time
tbst
incub
h
rt
horseradish
peroxidaseconjug
antiguinea
pig
rabbit
secondari
antibodi
dako
dilut
block
buffer
wash
membran
react
tetrahydrochlorid
pierc
rockford
il
usa
substrat
stop
distil
water
load
control
monoclon
antibodi
santa
cruz
biotechnolog
also
use
western
blot
analysi
spectrofluorometr
assay
proteolyt
activ
carri
use
synthet
fluorogen
substrat
coumarin
afc
measur
activ
coumarin
amc
measur
activ
bd
apoalert
caspas
fluoresc
assay
kit
clontech
laboratori
usa
use
determin
activ
brief
confluent
monolay
cell
grown
flask
infect
ibdv
moi
without
proteasom
inhibitor
treatment
infect
h
pi
cell
harvest
g
min
cell
lyse
lysi
buffer
ice
min
centrifug
g
min
supernat
collect
supernat
ad
equal
volum
reactiondtt
buffer
supplement
substrat
devdafc
substrat
lehdamc
incub
h
optic
densiti
nm
nm
determin
nanomol
afc
amc
releas
express
per
hour
calcul
standard
curv
viral
infect
frequent
result
degrad
proteasom
infect
cell
assess
whether
system
play
role
ibdv
infect
two
chemic
distinct
proteasom
inhibitor
lactacystin
use
address
question
peptidealdehyd
highli
potent
revers
inhibitor
chymotrypticlik
activ
proteasom
contrast
lactacystin
highli
specif
inhibit
proteasom
irrevers
action
catalyt
threonin
proteasom
preliminari
experi
cell
infect
ibdv
strain
lm
moi
incub
h
treatment
describ
elsewher
result
indic
viral
titer
supernat
infect
cell
h
infect
significantli
decreas
incub
h
compar
incub
proteasom
inhibitor
h
data
shown
therefor
subsequ
experi
treat
infect
cell
proteasom
inhibitor
h
determin
whether
ibdv
product
dosedepend
reduc
proteasom
inhibitor
treatment
cell
infect
ibdv
strain
lm
treat
variou
concentr
proteasomespecif
inhibitor
h
infect
input
proteasom
inhibitor
remov
replac
growth
medium
without
inhibitor
supernat
collect
h
pi
amount
progeni
viru
determin
titrat
use
assay
cell
fig
ibdv
replic
untreat
cell
result
gener
viral
titer
ml
h
pi
wherea
proteasom
inhibit
reduc
titer
releas
viru
supernat
dosedepend
manner
lactacystin
similar
inhibitori
effect
viru
product
data
indic
proteasom
inhibitor
significantli
block
ibdv
product
suggest
proteasom
may
play
import
role
ibdv
product
addit
also
use
differ
amount
ibdv
infect
cell
determin
effect
proteasom
inhibitor
viral
replic
viral
titer
supernat
harvest
h
pi
significantli
reduc
treatment
fig
impli
effect
due
reduct
viru
growth
rather
delay
viru
releas
differ
amount
input
viru
chang
absolut
amount
progeni
viru
affect
significantli
percentag
reduct
viral
titer
indic
antivir
properti
proteasom
inhibitor
independ
multipl
infect
mani
virus
capabl
induc
cell
death
lead
lysi
infect
cell
late
stage
ibdv
infect
morpholog
chang
commonli
known
cpe
microscop
observ
ibdvinduc
cpe
character
cell
round
shrinkag
deform
nuclei
chromatin
condens
detach
infect
cell
cultur
flask
cell
lysi
death
use
mtsbase
assay
test
cytotox
proteasom
inhibitor
note
throughout
dose
proteasom
inhibitor
use
studi
cell
viabil
assay
morpholog
assess
show
detect
cell
death
cell
data
shown
contrast
ibdvinduc
cpe
cell
death
dramat
block
addit
fig
infect
cell
ibdv
strain
lm
use
clear
cpe
visibl
within
h
pi
figur
show
morpholog
cell
infect
ibdv
mockinfect
cell
cell
treat
variou
amount
show
typic
spreadout
shape
normal
morpholog
addit
upon
infect
inhibit
format
visibl
cpe
thu
cpe
viru
infect
prevent
presenc
elucid
mechan
inhibit
took
advantag
revers
natur
dissect
potenti
target
proteasom
inhibitor
cell
infect
ibdv
ad
kept
media
three
differ
interv
shown
fig
cell
incub
h
pi
supernat
collect
viru
titrat
treatment
h
result
signific
reduct
viru
yield
reduct
compar
titer
notreat
control
viru
titer
group
treat
h
log
unit
lower
titer
control
sampl
viru
accumul
h
pi
slight
reduct
viru
titer
observ
viru
titer
h
h
h
treatment
group
compar
notreat
control
indic
signific
effect
late
step
viral
life
cycl
result
suggest
system
like
involv
earli
step
viru
life
cycl
sinc
inhibitori
effect
seen
primarili
treatment
group
describ
proteasom
inhibitor
inhibitori
effect
ibdv
infect
earli
step
reveal
possibl
mechan
inhibit
viru
intern
assay
perform
pretreat
cell
incub
ibdv
h
allow
viru
bind
incub
addit
hour
allow
viru
intern
afterward
fresh
medium
without
ad
cell
incub
h
pi
supernat
collect
viru
titrat
differ
viru
titer
presenc
absenc
proteasom
inhibitor
fig
result
suggest
system
involv
viru
intern
confirm
effect
proteasom
inhibitor
ibdv
viral
product
reduct
ibdv
rna
level
perform
realtim
rtpcr
analysi
rna
extract
cell
h
infect
ibdv
presenc
absenc
proteasom
inhibitor
amount
viral
mrna
normal
mrna
sampl
abund
mrna
dosedepend
decreas
ibdvinfect
cell
treat
proteasom
inhibitor
fig
studi
inhibitori
effect
proteasom
inhibitor
viral
protein
express
capsid
protein
ibdv
analyz
ibdvinfect
cell
ifa
detect
well
western
blot
ifa
detect
larg
amount
cell
posit
ibdv
protein
express
detect
h
pi
wherea
group
show
signific
reduct
amount
cell
posit
ibdv
protein
express
dosedepend
manner
fig
data
shown
western
blot
analysi
signific
amount
ibdv
protein
protein
extract
infect
cell
detect
h
pi
time
point
treatment
proteasom
inhibitor
reduc
dosedepend
express
capsid
protein
fig
result
suggest
proteasom
inhibitor
decreas
viral
replic
via
suppress
viral
rna
transcript
protein
translat
ibdv
shown
induc
apoptosi
cultur
cell
activ
follow
activ
pathway
demonstr
ibdv
replic
strongli
prevent
treatment
proteasom
inhibitor
determin
whether
ibdvinduc
apoptosi
associ
viral
replic
activ
cell
ibdv
infect
treatment
variou
amount
proteasom
inhibitor
expect
ibdv
strain
lm
induc
activ
infect
cell
wherea
activ
significantli
reduc
infect
cell
treat
acdevdcho
peptid
inhibitor
activ
lehdcho
inhibitor
activ
fig
furthermor
activ
dosedepend
decreas
infect
cell
treat
increas
amount
fig
result
indic
ibdvinduc
apoptosi
close
relat
viral
replic
assess
mechan
apoptosi
induc
ibdv
determin
effect
proteasom
inhibitor
cytochrom
c
releas
infect
cell
cytosol
fraction
ibdvinfect
cell
without
treatment
use
demonstr
local
cytochrom
c
western
blot
analysi
shown
fig
ibdv
induc
releas
cytochrom
c
cytoplasm
infect
cell
level
cytochrom
c
thu
rose
cytosol
fraction
infect
cell
fig
wherea
could
sequest
mitochondria
mockinfect
cell
data
shown
howev
releas
cytochrom
c
mitochondria
cytosol
dosedepend
decreas
ibdvinfect
cell
treat
proteasom
inhibitor
fig
data
shown
therefor
result
indic
ibdv
could
trigger
efflux
cytochrom
c
mitochondria
cytoplasm
infect
activ
seri
caspas
turn
induc
apoptosi
furthermor
apoptot
activ
induc
ibdv
could
strongli
reduc
proteasom
inhibitor
due
inhibit
viral
replic
recent
sever
virus
found
requir
activ
proteasom
retrovirus
requir
proteasom
bud
cell
human
cytomegaloviru
induc
cell
cycl
progress
simian
viru
human
parainfluenza
viru
type
block
ifn
signal
viru
herp
simplex
viru
regul
viral
latenc
minut
viru
mice
nuclear
transloc
murin
coronaviru
transfer
endosom
cytoplasm
viral
entri
adenoviru
requir
activ
proteasom
promot
late
gene
express
coxsackieviru
viral
rna
transcript
protein
synthesi
present
studi
show
proteasom
inhibitor
decreas
ibdv
replic
via
suppress
viral
rna
transcript
fig
protein
translat
fig
c
show
system
involv
earli
step
ibdv
replic
block
viru
intern
fig
b
howev
whether
pathwaymedi
ibdv
replic
relat
ubiquitin
process
andor
proteasom
degrad
clear
examin
proteasom
activ
follow
ibdv
infect
determin
effect
proteasom
inhibitor
activ
proteasom
activ
unchang
ibdvinfect
cell
wherea
proteasom
inhibitor
dramat
inhibit
proteasom
activ
mock
ibdvinfect
cell
data
shown
addit
also
observ
signific
accumul
polyubiquitin
protein
treatment
western
blot
analysi
data
shown
therefor
ubiquitin
process
may
play
role
pathwaymedi
ibdv
replic
protein
degrad
recent
report
liu
vakharia
demonstr
proteasom
inhibitor
complet
abl
inhibit
activ
well
ibdvinduc
dna
ladder
activ
thu
suggest
prevent
ibdvinduc
apoptosi
via
strong
inhibit
activ
requir
ibdvinduc
apoptosi
howev
ibdv
rna
transcript
protein
synthesi
infect
cell
presenc
avail
studi
studi
ibdv
rna
transcript
protein
synthesi
significantli
inhibit
ibdvinfect
cell
treatment
fig
activ
dosedepend
reduc
treatment
variou
concentr
fig
therefor
suggest
proteasom
inhibitor
decreas
ibdv
infect
antiapoptot
effect
proteasom
inhibitor
may
due
reduc
viral
replic
research
data
show
mitochondri
apoptot
pathway
activ
follow
infect
wide
varieti
virus
releas
cytochrom
c
mitochondria
wellknown
event
apoptosi
often
requir
format
downstream
caspas
studi
first
time
demonstr
cytochrom
c
also
locat
cytoplasm
ibdvinfect
cell
assay
westernblot
fig
furthermor
level
cytochrom
c
cytosol
fraction
dosedepend
reduc
treatment
variou
concentr
fig
releas
cytochrom
c
activ
concert
cytoplasm
factor
datp
result
lead
consequ
activ
therefor
ibdvinduc
apoptosi
cultur
cell
suggest
ibdv
capabl
influenc
mitochondri
function
lead
releas
cytochrom
c
cytoplasm
relat
level
viral
replic
trigger
latent
activ
caspas
activ
apoptosi
conclus
present
studi
demonstr
inhibit
pathway
effect
reduc
ibdv
replic
cultur
cell
determin
decreas
viral
rna
transcript
protein
synthesi
suggest
antiapoptot
effect
proteasom
inhibitor
may
due
reduc
ibdv
viral
replic
